The active substance mandipropamid, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Art. 1 Commission Implementing Regulation (EU) No 188/2013 of 5 March 2013 approving the active…
Approval of active substance
In forcesince 5 Mar 2013